Manuel Jonathan Fragoso-Vázquez

Deciphering the GPER/GPR30-agonist and antagonists interactions using molecular modeling studies, molecular dynamics, and docking simulations

David Méndez-Luna, Marlet Martínez‐Archundia, Rachid C. Maroun et al. · Journal of Biomolecular Structure and Dynamics · 2015 · 73 citations

N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed <i>in silico</i> with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells

Berenice Prestegui-Martel, Jorge Antonio Bermúdez-Lugo, Alma Chávez‐Blanco et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2016 · 42 citations · Full text

Neuroprotective Effects of Apocynin and Galantamine During the Chronic Administration of Scopolamine in an Alzheimer’s Disease Model

Eliezer Joseph, Daniel Miguel Ángel Villalobos-Acosta, Mónica Torres-Ramos et al. · Journal of Molecular Neuroscience · 2019 · 40 citations

Neurodegenerative Diseases, Alzheimer's Disease, Neurobiology Of Disease +12

In silico search, chemical characterization and immunogenic evaluation of amino-terminated G4-PAMAM-HIV peptide complexes using three-dimensional models of the HIV-1 gp120 protein

Rolando Alberto Rodríguez-Fonseca, Martiniano Bello, María Ángeles de los Muñoz-Fernández et al. · Colloids and Surfaces B Biointerfaces · 2019 · 26 citations

Three-dimensional Models, Biochemistry, Natural Sciences +12

Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells

Alberto Martínez-Muñoz, Berenice Prestegui-Martel, David Méndez-Luna et al. · Anti-Cancer Agents in Medicinal Chemistry · 2018 · 19 citations